We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLNE icon
2326
Clean Energy Fuels
CLNE
$416M
$1.24M ﹤0.01%
+155,630
New +$1.05M
JBI icon
2327
Janus International
JBI
$702M
$1.24M ﹤0.01%
+137,522
New +$1.4M
FPXI icon
2328
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$261M
$1.23M ﹤0.01%
25,202
+2,076
+9% +$105K
AZTA icon
2329
Azenta
AZTA
$1.3B
$1.23M ﹤0.01%
14,856
-3,207
-18% -$275K
SB icon
2330
Safe Bulkers
SB
$772M
$1.23M ﹤0.01%
257,689
-284,010
-52% -$1.16M
CPUH.WS
2331
CALL
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$1.22M ﹤0.01%
125,233
CLAA.WS
2332
CALL
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$1.22M ﹤0.01%
125,344
LOVE icon
2333
LoveSac
LOVE
$242M
$1.22M ﹤0.01%
22,603
-297,857
-93% -$14.3M
ODP
2334
DELISTED
ODP
ODP
$1.22M ﹤0.01%
26,662
-52,969
-67% -$2.32M
SGII
2335
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$1.22M ﹤0.01%
123,343
+82,343
+201% +$813K
EOCW.WS
2336
CALL
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$1.22M ﹤0.01%
124,995
NVAX icon
2337
Novavax
NVAX
$1.21B
$1.22M ﹤0.01%
16,554
-29,037
-64% -$2.59M
MDC
2338
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.22M ﹤0.01%
32,191
+3,027
+10% +$138K
UHAL icon
2339
U-Haul Holding Co
UHAL
$14B
$1.22M ﹤0.01%
20,340
+13,220
+186% +$815K
EDTX
2340
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$1.22M ﹤0.01%
120,299
WF icon
2341
Woori Financial
WF
$15.9B
$1.21M ﹤0.01%
32,094
+14,959
+87% +$541K
ICE icon
2342
Intercontinental Exchange
ICE
$87.2B
$1.21M ﹤0.01%
9,141
-70,382
-89% -$9.09M
FRXB.WS
2343
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$1.21M ﹤0.01%
123,581
ALACW
2344
CALL
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$1.21M ﹤0.01%
100,000
RTB
2345
RTB Digital
RTB
$230M
$1.2M ﹤0.01%
+814
New +$1.02M
PCB icon
2346
PCB Bancorp
PCB
$394M
$1.2M ﹤0.01%
52,330
+20,742
+66% +$482K
GE icon
2347
GE Aerospace
GE
$364B
$1.2M ﹤0.01%
+20,950
New +$1.25M
EWA icon
2348
iShares MSCI Australia ETF
EWA
$1.38B
$1.19M ﹤0.01%
+45,176
New +$1.1M
FICO icon
2349
Fair Isaac
FICO
$31.8B
$1.19M ﹤0.01%
2,549
-60,571
-96% -$28.6M
WPCA.WS
2350
CALL
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$1.19M ﹤0.01%
120,420

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.